Brief: Bioporto A/S submits FDA application for NGAL test

BioPorto A/S

18/07/2018 20:11

July 18 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * BIOPORTO SUBMITS FDA APPLICATION FOR NGAL TEST
    * ASSUMING A STANDARD REVIEW PROCESS FROM FDA, A DECISION
REGARDING APPLICATION COULD BE EXPECTED IN SECOND HALF OF 2018
    * SUBMISSION OF FDA APPLICATION DOES NOT ALTER BIOPORTO'S
FINANCIAL GUIDANCE FOR 2018
    * IF NGAL TEST IS CLEARED BY FDA IN EXPECTED TIMEFRAME, CO
WILL BE
IN POSITION TO COMMENCE COMMERCIALIZING NGAL TEST BY LATE 2018
OR EARLY 2019 IN US

Source text for Eikon:  ID:nGNE4WK3gt 
Further company coverage:  BIOPOR.CO 

 ((Reuters.Briefs@thomsonreuters.com;))